false
--12-31
0001787518
Nukkleus Inc.
0001787518
2026-02-09
2026-02-09
0001787518
NUKK:CommonStock0.0001ParValuePerShareMember
2026-02-09
2026-02-09
0001787518
NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember
2026-02-09
2026-02-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 9, 2026
T3 DEFENSE INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-39341 |
|
38-3912845 |
(State or other jurisdiction of
incorporation or organization) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
575
Fifth Avenue, 14th Floor
New York, New York 10017
(Address of principal executive offices)
212-791-4663
(Registrant’s telephone number, including
area code)
Nukkleus Inc.
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.0001 par value per share |
|
DFNS |
|
The Nasdaq Stock Market LLC |
| |
|
|
|
|
| Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share |
|
DFNSW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.03 Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.
Effective February 9, 2026, Nukkleus Inc. (the
“Company”) changed its name by the filing of a certificate of correction to the Amendment to its Amended and Restated Certificate
of Incorporation with the Secretary of State of the State of Delaware to change the name of the Company to “T3 Defense Inc.”.
The change in the name of the Company was effectuated pursuant to Section 242(d)(1) of the Delaware General Corporation Law.
As a result of the name change, the new ticker
of the Company will be “DFNS”. The Company will commence trading under the new ticker symbol on The Nasdaq Stock Market LLC
on February 9, 2026. There is no change to the CUSIP of the Company.
Item 7.01 Regulation FD Disclosure.
On February 9, 2026, Nukkleus Inc. issued a press
release regarding the name change of the Company. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference.
The information contained in this Item 7.01, including
Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a
filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. |
|
Description |
| 3.8.1 |
|
Certificate of Correction. |
| 3.8.2 |
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation. |
| 99.1 |
|
Press Release dated February 9, 2026. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
T3 DEFENSE INC. |
| |
|
|
| Date: February 9, 2026 |
By: |
/s/ Menachem Shalom |
| |
Name: |
Menachem Shalom |
| |
Title: |
Chief Executive Officer |
Exhibit 99.1
Nukkleus Inc. Announces Corporate Rebranding:
Changes Name to T3 Defense Inc. and Ticker Symbol to DFNS
The name and ticker change reflects the company’s
strategic focus on acquiring and operating
mission-critical defense businesses that are deeply embedded in long-cycle national security
programs
TEL AVIV / NEW YORK – February 9, 2026 –
T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc. (NASDAQ:
NUKK), today announced a corporate rebrand that formalizes the company’s strategy as a holding entity focused on building the asymmetric
edge that shapes the future of defense by acquiring and scaling defense businesses positioned at structurally constrained points of the
industrial base. The rebrand to T3 Defense and the adoption of the DFNS ticker is intended to clarify the company’s positioning
for investors, customers, and its current and future strategic partners. The company’s common stock will continue to trade on the
NASDAQ under the new ticker symbol DFNS, effective February 9, 2026. No action is required by shareholders as a result of the name or
ticker symbol change.
Menny Shalom, CEO of T3 Defense noted, “Defense
bottlenecks don’t show up in headlines; they show up on factory floors, in qualification queues, and in programs that can’t
afford delays. We’ve built a portfolio of defense businesses with long-term contracts, deep qualifications, and real operating constraints.
T3 Defense is focused on scaling that execution across a federated portfolio, relieving pressure at critical choke points and strengthening
the industrial foundation required to support military readiness and operational effectiveness.”
As global defense spending accelerates, production
delays increasingly originate below the prime-contractor level, specifically specialized suppliers operating at program-critical points
across the defense industrial base, including suppliers supporting OEM platforms. This is where strategic value exists as they are difficult
to replace and slow to scale. Several of T3 Defense’s subsidiaries already operate at these pressure points, supporting programs
tied to air defense, homeland security, and AI for defense, among others. This includes participation in Israel’s national missile
defense and air-defense architecture, such as Iron Dome, alongside other multi-year defense contracts that provide revenue visibility
and operational continuity.
T3 Defense applies a disciplined, repeatable M&A
framework built around three distinct acquisition vectors: time-to-value execution, consisting of already-operating businesses where performance
improvements can be realized rapidly through pricing discipline, productivity gains, procurement optimization, and improved capacity utilization;
bottleneck and capacity, defined by scarce, difficult-to-replace production nodes and specialized processes that are critical to program
delivery; and qualification and access, comprising companies embedded in defense programs with established prime-contractor relationships,
compliance maturity, and customer trust that reduce switching risk and accelerate growth.
The new identity reflects an operating model the
company has been executing across its portfolio of defense subsidiaries, which support long-cycle national security programs and maintain
active contracts with leading defense original equipment manufacturers. These subsidiaries operate across engineering, manufacturing,
and software, supplying mission-critical components, systems, and capabilities embedded deep within defense programs where reliability,
qualification, and delivery certainty are paramount. By strengthening these critical industrial capabilities, T3 Defense aims to improve
OEM reliability, accelerate delivery timelines, and ensure defense forces receive mission-ready systems when operational demand requires
them.
Therefore, each acquisition is viewed as a building
block in a compounding system where existing contracts, qualifications, and operational experience increase the value and reduce the risk
of future acquisitions. By expanding scarce industrial capacity and deepening program-level access, the portfolio is designed to become
more scalable over time.
###
About T3 Defense Inc.
T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., is a federated
holding company focused on acquiring and operating mission-critical defense businesses embedded in long-cycle national security programs.
The company targets defense businesses operating at constrained, qualification-driven, or execution-critical points across the industrial
base where strategic value exists and where qualification, capacity, and execution are decisive. Through disciplined M&A, centralized
capital and strategy, and decentralized operating autonomy, T3 Defense seeks to strengthen critical defense capabilities and compound
long-term value.
Forward-Looking Statements
This press release contains forward-looking statements made pursuant
to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements other than statements of historical facts are “forward-looking statements” within the
meaning of federal securities laws. In some cases, forward-looking statements can be identified by terminology such as “will,”
“would,” “expect,” “intend,” “plan,” “believe,” “objective,” or
comparable terms referring to future events, conditions, or circumstances, or the negative of such terms.
Although T3 Defense Inc., formerly Nukkleus Inc., believes that it
has a reasonable basis for the forward-looking statements contained in this press release, such statements are based on management’s
current beliefs, assumptions, and expectations regarding future events and circumstances and are subject to a number of risks and uncertainties,
many of which are difficult to predict and beyond the Company’s control. Forward-looking statements include, but are not limited
to, statements regarding the Company’s strategy, acquisition plans, operating model, ability to execute disciplined M&A, expectations
regarding subsidiary performance, long-term contracts, revenue visibility, capacity expansion, and the anticipated benefits of the Company’s
federated holding company structure.
Actual results, performance, or achievements may differ materially
from those expressed or implied by forward-looking statements as a result of various factors, including but not limited to: the Company’s
ability to successfully integrate and operate acquired businesses; the performance and execution of contracts by the Company’s subsidiaries;
the availability and sufficiency of working capital to execute business plans and strategic initiatives; the Company’s ability to
identify and complete future acquisitions on acceptable terms; market acceptance of the Company’s offerings; changes in defense
spending, procurement practices, or regulatory requirements; geopolitical developments; and other risks described under the heading “Risk
Factors” in the Company’s Annual Report on Form 10-K, as updated by subsequent Quarterly Reports on Form 10-Q and other filings
with the Securities and Exchange Commission.
Forward-looking statements speak only as of the date they are made.
The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date
of this press release, except as required by law.
For more information, please contact:
Investor Relations (US)
Lena Cati
Tel: +1 212 836-9611
lcati@theequitygroup.com
Val Ferraro
Tel: +1 212 836-9612
vferraro@theequitygroup.com